Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
What Falling Estimates & Price Mean For Mattel (MAT) By Zacks Investment Research - Dec 17, 2017

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are...

Zacks Investment Research
DDR's Debt Rating Downgraded By Moody's Post Spin-Off News By Zacks Investment Research - Dec 17, 2017

DDR Corp. (NYSE:DDR) recently experienced a rating downgrade by Moody's Investors Service. Specifically, the rating of its senior unsecured debt has been downgraded by a notch to Baa3 from Baa2....

Zacks Investment Research
Lockheed (LMT) Wins $136M Deal To Aid Japan's Aegis System By Zacks Investment Research - Dec 17, 2017

Lockheed Martin Corporation’s (NYSE:LMT) business segment, Rotary and Missions Systems (RMS), recently secured a foreign military sales (FMS) contract for manufacturing DDG AEGIS weapon system...

Zacks Investment Research
Alliance Data's (ADS) November Average Receivables Improve By Zacks Investment Research - Dec 17, 2017

Alliance Data Systems Corporation’s (NYSE:ADS) average receivables of $17.7 billion increased 16% in November. For the eleven-month period ended in the same month this year, average...

Zacks Investment Research
Sanofi/Alnylam Say FDA Lifts Clinical Hold On Fitusiran By Zacks Investment Research - Dec 17, 2017

Sanofi (PA:SASY) (NYSE:SNY) and partner Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced that the FDA has lifted clinical hold placed on all ongoing studies of its hemophilia candidate...

Zacks Investment Research
Varian Gains Ground On New Applications, Grows In Australia By Zacks Investment Research - Dec 17, 2017

Varian Medical Systems (NYSE:VAR) recently announced that Australia-based Peter MacCallum Cancer Centre (also known as Peter Mac) has selected the company’s flagship Eclipse treatment planning...

Zacks Investment Research
Kraft Heinz (KHC) Focuses On Product Innovation, Sales Weak By Zacks Investment Research - Dec 17, 2017

Owing to the growing awareness of the nutritional value of food products among consumers, The Kraft Heinz Company (NASDAQ:KHC) is focusing on natural and organic ingredients, reshaping its existing...

Zacks Investment Research
Pick 5 Bargain Stocks With Attractive EV/EBITDA Ratios By Zacks Investment Research - Dec 17, 2017

The price-to-earnings (P/E) ratio is broadly considered by investors as a yardstick for assessing the fair market value of a stock. The idea of hunting for stocks with a low P/E is ingrained in the...

Kay Kim
Correction Looming On Citigroup By Kay Kim - Dec 17, 2017

I am now completely out of my Citigroup Inc (NYSE:C) CALLS as of Friday.I’ve decided to close it out because I see that Citi is now cultivating weekly-bearish divergence formation (chart above),...

Double Dividend Stocks
Stock Market News: 12/16/17 By Double Dividend Stocks - Dec 17, 2017

Markets: It was a mixed week again- with 3 out of 4 indexes gaining for the week and closing at record highs on Friday, as the Tax Bill advanced further through the legislative process. The Dow Jones...

Jeff Miller
The Week Ahead: Fresh Legs For The Stock Rally In 2018? By Jeff Miller - Dec 17, 2017

The economic calendar is loaded, especially with reports on housing. Despite this, the calendar and recent events will stimulate pundits to get out their crystal balls. I expect many to be asking:Can...

Continue with Apple
Continue with Google
or
Sign up with Email